Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HTR2A | P28223 | 12/20 | 0.55 |
| ▸ | HTR2C | P28335 | 5/20 | 0.47 |
| ▸ | HTR2B | P41595 | 5/20 | 0.47 |
| ▸ | HTR1A | P08908 | 4/20 | 0.47 |
| ▸ | HTR6 | P50406 | 3/20 | 0.47 |
| ▸ | HTR1D | P28221 | 2/20 | 0.46 |
| ▸ | HTR1B | P28222 | 2/20 | 0.46 |
| ▸ | HTR1E | P28566 | 2/20 | 0.46 |
| ▸ | HTR7 | P34969 | 2/20 | 0.46 |
| ▸ | HTR5A | P47898 | 2/20 | 0.46 |
| ▸ | HTR1F | P30939 | 2/20 | 0.46 |
| ▸ | HTR3E | A5X5Y0 | 1/20 | 0.46 |
| ▸ | HTR3B | O95264 | 1/20 | 0.46 |
| ▸ | HTR3A | P46098 | 1/20 | 0.46 |
| ▸ | HTR4 | Q13639 | 1/20 | 0.46 |
| ▸ | HTR3D | Q70Z44 | 1/20 | 0.46 |
| ▸ | HTR3C | Q8WXA8 | 1/20 | 0.46 |
| ▸ | MTNR1A | P48039 | 1/20 | 0.43 |
| ▸ | MTNR1B | P49286 | 1/20 | 0.43 |
| ▸ | DRD1 | P21728 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL24168355 | 1.00 | HTR2A (0.55) | HTR2AHTR2CHTR2BHTR1AHTR6 | |
| Hydrochloric Acid SCHEMBL30498783 | 0.99 | HTR2A (0.55) | HTR2AHTR2CHTR2BHTR1AHTR6 | |
| Methyl Alcohol SCHEMBL25423744 | 0.99 | HTR2A (0.55) | HTR2AHTR2CHTR2BHTR1AHTR6 | |
| Alcohol SCHEMBL25422778 | 0.98 | HTR2A (0.56) | HTR2AHTR2CHTR2BHTR1AHTR6 | |
| SCHEMBL27084904 | 0.98 | HTR2A (0.58) | HTR2AHTR2CHTR2BHTR1AHTR6 | |
| SCHEMBL27085057 | 0.97 | HTR2A (0.59) | HTR2AHTR2CHTR2BHTR1AHTR6 | |
| SCHEMBL25790828 | 0.96 | HTR2A (0.59) | HTR2AHTR2CHTR2BHTR1AHTR6 | |
| Hydrochloric Acid SCHEMBL31634307 | 0.95 | HTR2A (0.58) | HTR2AHTR2CHTR2BHTR1AHTR6 | |
| SCHEMBL25424214 | 0.94 | HTR2A (0.52) | HTR2AHTR2CHTR2BHTR1AHTR6 | |
| Hydrochloric Acid SCHEMBL25425250 | 0.93 | HTR2A (0.52) | HTR2AHTR2CHTR2BHTR1AHTR6 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 15 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12612364-B2 | Salts and solid forms of 4-hydroxy-N,N-diisopropyltryptamine hemi-glutarate and hemi-succinate | TERRAN BIOSCIENCES INC. (US) | 2026-04-28 | — | — | US | disclosed |
| US-20260085041-A1 | SALTS AND SOLID FORMS OF 4-HYDROXY-N,N-DIISOPROPYLTRYPTAMINE HEMI-GLUTARATE AND HEMI-SUCCINATE | TERRAN BIOSCIENCES INC (US) | 2026-03-26 | — | — | US | disclosed |
| US-20260049056-A1 | PSILOCYBIN DERIVATIVES | CAAMTECH, INC. (US) | 2026-02-19 | — | — | US | disclosed |
| US-20260049056-A1 | PSILOCYBIN DERIVATIVES | CAAMTECH, INC. (US) | 2026-02-19 | — | — | US | disclosed |
| US-12404238-B2 | Psilocybin derivatives | CAAMTECH, INC. (US) | 2025-09-02 | — | — | US | disclosed |
| US-12404238-B2 | Psilocybin derivatives | CAAMTECH, INC. (US) | 2025-09-02 | — | — | US | disclosed |
| US-20250066299-A1 | SALTS AND SOLID FORMS OF 4-HYDROXY-N,N-DIISOPROPYLTRYPTAMINE HEMI-GLUTARATE AND HEMI-SUCCINATE | TERRAN BIOSCIENCES INC (US) | 2025-02-27 | — | — | US | disclosed |
| US-20240417373-A1 | PSILOCYBIN DERIVATIVES | CAAMTECH, INC. | 2024-12-19 | — | — | US | disclosed |
| US-20240417373-A1 | PSILOCYBIN DERIVATIVES | CAAMTECH, INC. | 2024-12-19 | — | — | US | disclosed |
| US-20240342126-A1 | HALLUCINOGEN-FATTY ACID COMBINATION | MINDSET PHARMA INC. (CA) | 2024-10-17 | — | — | US | disclosed |
| EP-4444698-A1 | PSILOCYBIN DERIVATIVES | Caamtech, Inc. (US) | 2024-10-16 | — | — | EP | disclosed |
| EP-4444698-A1 | PSILOCYBIN DERIVATIVES | Caamtech, Inc. (US) | 2024-10-16 | — | — | EP | disclosed |
| CN-117120415-A | Modified indole alkaloids for therapeutic use | 指南针探路者有限公司 | 2023-11-24 | — | — | CN | disclosed |
| WO-2023108167-A1 | PSILOCYBIN DERIVATIVES | CAAMTECH, INC. (US) | 2023-06-15 | — | — | WO | disclosed |
| WO-2023108167-A1 | PSILOCYBIN DERIVATIVES | CAAMTECH, INC. (US) | 2023-06-15 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (7 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12612364-B2 | Salts and solid forms of 4-hydroxy-N,N-diisopropyltryptamine hemi-glutarate and hemi-succinate | SLC6A4, DLST, GRIN2D | HTR2A 111/4885HTR2C 66/4885HTR2B 419/4885 |
| US-20240342126-A1 | HALLUCINOGEN-FATTY ACID COMBINATION | FAAH, HTR5A, FAAH2 | HTR2A 8/4885HTR2C 5/4885HTR2B 16/4885 |
| US-20260049056-A1 | PSILOCYBIN DERIVATIVES | OTC, PSAT1, TPH1 | HTR2A 340/4885HTR2C 48/4885HTR2B 154/4885 |
| US-12404238-B2 | Psilocybin derivatives | SLC6A4, PNMT, INMT | HTR2A 73/4885HTR2C 16/4885HTR2B 38/4885 |
| US-20260085041-A1 | SALTS AND SOLID FORMS OF 4-HYDROXY-N,N-DIISOPROPYLTRYPTAMINE HEMI-GLUTARATE AND HEMI-SUCCINATE | SLC6A4, DLST, GRIN2D | HTR2A 111/4885HTR2C 66/4885HTR2B 419/4885 |
| US-20250066299-A1 | SALTS AND SOLID FORMS OF 4-HYDROXY-N,N-DIISOPROPYLTRYPTAMINE HEMI-GLUTARATE AND HEMI-SUCCINATE | SLC6A4, SLC6A3, SLC6A2 | HTR2A 91/4885HTR2C 60/4885HTR2B 168/4885 |
| US-20240417373-A1 | PSILOCYBIN DERIVATIVES | SLC6A4, PNMT, INMT | HTR2A 73/4885HTR2C 16/4885HTR2B 38/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.